Print |
Bookmark |
Font Size:
+ |
–
Medical Review News and Publications
| Topic |
Publication Date |
Last Revised/Reviewed |
| Date of Service Policy |
06.30.2026 |
|
| TPE Provider Contact Information |
01.15.2026 |
|
| PXR Response to Comments |
12.15.2025 |
|
| Claim Resubmission/Rebilling |
04.22.2025 |
|
| Billing Not Otherwise Classified (NOC) HCPCS Code |
03.18.2025 |
|
| Billing the Professional and Technical Components |
02.27.2025 |
|
| Proper Billing of Tuberculosis Tests |
07.16.2024 |
|
| Utilizing Modifier KX for Medicare Dental Claims |
07.01.2024 |
|
| Documentation Guidelines for Evaluation & Management (E/M) Services: Reminders and Updates |
04.09.2024 |
|
| Billing and Coding: JW and JZ Modifier Guidelines |
06.27.2023 |
|
When You Don't Respond to Additional Documentation Requests (ADRs): Quick Reference Guide |
06.16.2023 |
|
| Medicare Dental Service Coverage Update |
06.08.2023 |
|
| J15 Targeted Probe Educate Review Status |
05.25.2023 |
|
| Targeted Probe and Educate Program to Focus on Laboratory Testing |
05.25.2023 |
|
| Targeted Probe and Educate Program to Focus on Annual Wellness Visits |
05.25.2023 |
|
| SPRAVATO™ (esketamine) nasal spray, CIII |
05.01.2023 |
12.21.2023 |
| NCD 110.24: Chimeric Antigen Receptor (CAR) T-Cell Therapy Billing Instructions |
03.10.2023 |
|
| Targeted Probe and Education Program to Focus on Spinal Pain Management Claims |
01.04.2023 |
|
| MolDX: Pharmacogenomics Testing Policy Article Update |
03.14.2022 |
|
| Triamcinolone Acetonide Injectable Suspension, for Suprachoroidal Use (Xipere™) Billing and Coding Instructions |
01.25.2022 |
|
| Sinus Implant Billing and Coding Instructions |
01.21.2022 |
|
| Radioactive Diagnostic Agents for Positron Emission Tomography (PET) of Prostate-Specific Membrane Antigen (PSMA) Positive Lesions in Men with Prostate Cancer Billing and Coding Instructions |
01.20.2022 |
|
| Billing VEKLURY™ (Remdesivir) Antiviral Medication in Outpatient Settings |
01.18.2022 |
|
| Qutenza (capsaicin 8% topical system) Billing and Coding Instructions |
11.08.2021 |
|
| Piflufolastat F-18 ("Pylarify")(18F-DCFPyl or PyL) Billing and Coding Instructions |
10.21.2021 |
|
| Targeted Probe and Educate (TPE) Process |
09.02.2021 |
|
| Split/Shared Services |
03.22.2021 |
07.16.24 |
| J15 Post Pay Resumptive Review Status Update 08/17/2020 – 12/31/2020 |
03.02.2021 |
|
| J15 Targeted Probe and Educate Status Update July 1, 2019 – September 30, 2019 |
11.22.2019 |
|
| J15 Targeted Probe and Educate Status Update: April 1, 2019 – June 30, 2019 |
08.29.2019 |
|
| Prolonged Services (CPT Codes 99354 – 99359) |
08.21.2019 |
|
| Q4 J15 Targeted Probe and Educate Status Update |
02.01.2019 |
|
| CGS Part B Reviews of Frequency of E/M Office Visits |
10.30.2018 |
|
| Policy Updates: New, Retired, Annual ICD-10 Changes |
10.23.2018 |
|
| Portable X-Ray Benefit |
09.19.2018 |
|
| Who May Report CPT Codes 99304 – 99306Â Initial Nursing Facility Care |
09.18.2018 |
|
| Independent Diagnostic Testing Facility (IDTF) Performance Standards (V10) |
05.02.2018 |
10.16.2020 |
| How to Avoid Lab Errors |
02.27.2018 |
08.06.2018 |
| What Are Acceptable Electronic Signature Notations? |
09.26.2017 |
01.14.2022 |
| Important: JW Modifier Use Change Effective July 1, 2016 |
06.01.2016 |
06.20.2016 |
| CGS-MolDX: Next Generation Sequencing (NGS) and Tier 1 and Tier 2 Coding and Billing Guidelines (CM00096) |
02.09.2016 |
|
| Signatures and Compliance: Practitioner Offices and Billing Services |
03.06.2014 |
12.13.2023 |
| Teaching Physician Services: Supervision, Documentation, and HCPCS Modifier GC |
09.19.2013 |
05.07.2019 |
| Breast Tomosynthesis: Coverage and Claim Submission Instructions |
09.06.2013 |
01.13.2015 |
| Invoice Claim Filing Instructions |
03.07.2013 |
|
Updated: 06.30.2026
Reviewed: 06.30.2026